Mirati Therapeutics Competitors and Similar CompaniesClear all
Mirati Therapeutics's competitors and similar companies include Tetherex and Adagene.
 Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. |  Tetherex Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. |  Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. | |
Founding Date | Founding Date 2013 | Founding Date 2014 | Founding Date 2012 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ Zug, CH | Locations Oklahoma City, US HQ Morrisville, US | Locations Suzhou, CN HQ San Diego, US San Francisco, US |
Employees | Employees 666% decrease | Employees N/A | Employees 13821% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $12.4m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods $600k (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $11.8m (FY, 2022) | Gross profit N/A | Gross profit $7.7m (FY, 2025) |
Net income | Net income ($740.9m) (FY, 2022) | Net income N/A | Net income ($17.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 46.2m | Total funding raised $ 155m |
For sources of this data, please see the company profile
View Company Profiles
Tetherex
HQ
Oklahoma City, US
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
View companyAdagene
HQ
Suzhou, CN
Employees
138↓ 21% decrease
Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
View company